Corcept Therapeutics Inc (CORT)
54.79
-1.66
(-2.94%)
USD |
NASDAQ |
Nov 14, 16:00
54.44
-0.35
(-0.64%)
After-Hours: 20:00
Corcept Therapeutics Cash from Operations (Quarterly): 73.83M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 73.83M |
| June 30, 2024 | 41.18M |
| March 31, 2024 | 23.76M |
| December 31, 2023 | 5.887M |
| September 30, 2023 | 52.91M |
| June 30, 2023 | 42.29M |
| March 31, 2023 | 25.96M |
| December 31, 2022 | 33.39M |
| September 30, 2022 | 33.65M |
| June 30, 2022 | 18.04M |
| March 31, 2022 | 35.25M |
| December 31, 2021 | 49.43M |
| September 30, 2021 | 48.70M |
| June 30, 2021 | 44.34M |
| March 31, 2021 | 25.42M |
| December 31, 2020 | 35.07M |
| September 30, 2020 | 30.44M |
| June 30, 2020 | 53.19M |
| March 31, 2020 | 33.27M |
| December 31, 2019 | 48.45M |
| September 30, 2019 | 38.43M |
| June 30, 2019 | 25.56M |
| March 31, 2019 | 23.68M |
| December 31, 2018 | 21.52M |
| September 30, 2018 | 44.50M |
| Date | Value |
|---|---|
| June 30, 2018 | 15.21M |
| March 31, 2018 | 34.43M |
| December 31, 2017 | 24.88M |
| September 30, 2017 | 10.92M |
| June 30, 2017 | 15.57M |
| March 31, 2017 | 9.561M |
| December 31, 2016 | 4.569M |
| September 30, 2016 | 8.935M |
| June 30, 2016 | 1.59M |
| March 31, 2016 | 3.297M |
| December 31, 2015 | 4.163M |
| September 30, 2015 | 0.883M |
| June 30, 2015 | -0.139M |
| March 31, 2015 | -1.777M |
| December 31, 2014 | -1.403M |
| September 30, 2014 | -5.929M |
| June 30, 2014 | -8.984M |
| March 31, 2014 | -11.06M |
| December 31, 2013 | -7.666M |
| September 30, 2013 | -8.602M |
| June 30, 2013 | -9.236M |
| March 31, 2013 | -11.55M |
| December 31, 2012 | -8.742M |
| September 30, 2012 | -9.229M |
| June 30, 2012 | -7.892M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
5.887M
Minimum
Dec 2023
73.83M
Maximum
Sep 2024
37.72M
Average
35.16M
Median
Cash from Operations (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 72.87M |
| ADMA Biologics Inc | 25.03M |
| Akebia Therapeutics Inc | -6.695M |
| Bioventus Inc | 10.32M |
| Alnylam Pharmaceuticals Inc | 43.71M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -44.04M |
| Cash from Financing (Quarterly) | -21.09M |
| Free Cash Flow | 142.60M |
| Free Cash Flow Per Share (Quarterly) | 0.6348 |
| Free Cash Flow to Equity (Quarterly) | 72.19M |
| Free Cash Flow to Firm (Quarterly) | 72.19M |
| Free Cash Flow Yield | 2.34% |